APO Research
Talk to an analyst

APO RESEARCH · REPORT

Integrin Alpha 4

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Integrin Alpha 4 Market Analysis and Forecast 2026-2032

26 December 2025195 pages

Choose your research edition.

Industry ResearchIntegrin Alpha 4 Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrin Alpha 4 Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Integrin Alpha 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrin Alpha 4 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrin Alpha 4 Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Integrin Alpha 4 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Integrin Alpha 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Integrin Alpha 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Integrin Alpha 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Integrin Alpha 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Integrin Alpha 4 include Takeda Pharmaceutical Co Ltd, Viriom Inc, Protagonist Therapeutics Inc, Morphic Therapeutic Inc, Immunwork Inc, EA Pharma Co Ltd, Daiichi Sankyo Co Ltd, BioMAS Ltd and Biogen Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Integrin Alpha 4, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Integrin Alpha 4, also provides the sales of main regions and countries. Of the upcoming market potential for Integrin Alpha 4, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Integrin Alpha 4 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Integrin Alpha 4 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Integrin Alpha 4 sales, projected growth trends, production technology, application and end-user industry.

Integrin Alpha 4 Segment by Company

Takeda Pharmaceutical Co Ltd

Viriom Inc

Protagonist Therapeutics Inc

Morphic Therapeutic Inc

Immunwork Inc

EA Pharma Co Ltd

Daiichi Sankyo Co Ltd

BioMAS Ltd

Biogen Inc

Antisense Therapeutics Ltd

Amgen Inc

Integrin Alpha 4 Segment by Type

ATL-1102

Carotegrast

ET-3764

TE-5232

Others

Integrin Alpha 4 Segment by Application

Acute Ischemic Stroke

Melanoma

Celiac Disease

Multiple Sclerosis

Epilepsy

Other

Integrin Alpha 4 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrin Alpha 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrin Alpha 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrin Alpha 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Integrin Alpha 4 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Integrin Alpha 4 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Integrin Alpha 4 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Integrin Alpha 4 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ATL-1102 Major Manufacturers Table 3. Carotegrast Major Manufacturers Table 4. ET-3764 Major Manufacturers Table 5. TE-5232 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Integrin Alpha 4 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Acute Ischemic Stroke Major Manufacturers Table 9. Melanoma Major Manufacturers Table 10. Celiac Disease Major Manufacturers Table 11. Multiple Sclerosis Major Manufacturers Table 12. Epilepsy Major Manufacturers Table 13. Other Major Manufacturers Table 14. Integrin Alpha 4 Industry Trends Table 15. Integrin Alpha 4 Industry Drivers Table 16. Integrin Alpha 4 Industry Opportunities and Challenges Table 17. Integrin Alpha 4 Industry Restraints Table 18. Global Integrin Alpha 4 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Integrin Alpha 4 Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Integrin Alpha 4 Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Integrin Alpha 4 Revenue Market Share by Region (2021-2026) Table 22. Global Integrin Alpha 4 Revenue Market Share by Region (2027-2032) Table 23. Global Integrin Alpha 4 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 24. Global Integrin Alpha 4 Sales by Region (2021-2026) & (W Units) Table 25. Global Integrin Alpha 4 Sales by Region (2027-2032) & (W Units) Table 26. Global Integrin Alpha 4 Sales Market Share by Region (2021-2026) Table 27. Global Integrin Alpha 4 Sales Market Share by Region (2027-2032) Table 28. Global Integrin Alpha 4 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Integrin Alpha 4 Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Integrin Alpha 4 Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Integrin Alpha 4 Sales Market Share by Manufacturers (2021-2026) Table 32. Global Integrin Alpha 4 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 33. Global Integrin Alpha 4 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Integrin Alpha 4 Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Integrin Alpha 4 Manufacturers, Product Type & Application Table 36. Global Integrin Alpha 4 Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Integrin Alpha 4 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Integrin Alpha 4 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Integrin Alpha 4 Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Integrin Alpha 4 Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Integrin Alpha 4 Revenue Market Share by Type (2021-2026) Table 43. Global Integrin Alpha 4 Revenue Market Share by Type (2027-2032) Table 44. Global Integrin Alpha 4 Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 45. Global Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 46. Global Integrin Alpha 4 Sales by Type (2027-2032) & (W Units) Table 47. Global Integrin Alpha 4 Sales Market Share by Type (2021-2026) Table 48. Global Integrin Alpha 4 Sales Market Share by Type (2027-2032) Table 49. Global Integrin Alpha 4 Price by Type (2021-2026) & (US$/Unit) Table 50. Global Integrin Alpha 4 Price by Type (2027-2032) & (US$/Unit) Table 51. Global Integrin Alpha 4 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Integrin Alpha 4 Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Integrin Alpha 4 Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Integrin Alpha 4 Revenue Market Share by Application (2021-2026) Table 55. Global Integrin Alpha 4 Revenue Market Share by Application (2027-2032) Table 56. Global Integrin Alpha 4 Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 57. Global Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 58. Global Integrin Alpha 4 Sales by Application (2027-2032) & (W Units) Table 59. Global Integrin Alpha 4 Sales Market Share by Application (2021-2026) Table 60. Global Integrin Alpha 4 Sales Market Share by Application (2027-2032) Table 61. Global Integrin Alpha 4 Price by Application (2021-2026) & (US$/Unit) Table 62. Global Integrin Alpha 4 Price by Application (2027-2032) & (US$/Unit) Table 63. Takeda Pharmaceutical Co Ltd Company Information Table 64. Takeda Pharmaceutical Co Ltd Business Overview Table 65. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolio Table 67. Takeda Pharmaceutical Co Ltd Recent Development Table 68. Viriom Inc Company Information Table 69. Viriom Inc Business Overview Table 70. Viriom Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Viriom Inc Integrin Alpha 4 Product Portfolio Table 72. Viriom Inc Recent Development Table 73. Protagonist Therapeutics Inc Company Information Table 74. Protagonist Therapeutics Inc Business Overview Table 75. Protagonist Therapeutics Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Protagonist Therapeutics Inc Integrin Alpha 4 Product Portfolio Table 77. Protagonist Therapeutics Inc Recent Development Table 78. Morphic Therapeutic Inc Company Information Table 79. Morphic Therapeutic Inc Business Overview Table 80. Morphic Therapeutic Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Morphic Therapeutic Inc Integrin Alpha 4 Product Portfolio Table 82. Morphic Therapeutic Inc Recent Development Table 83. Immunwork Inc Company Information Table 84. Immunwork Inc Business Overview Table 85. Immunwork Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Immunwork Inc Integrin Alpha 4 Product Portfolio Table 87. Immunwork Inc Recent Development Table 88. EA Pharma Co Ltd Company Information Table 89. EA Pharma Co Ltd Business Overview Table 90. EA Pharma Co Ltd Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. EA Pharma Co Ltd Integrin Alpha 4 Product Portfolio Table 92. EA Pharma Co Ltd Recent Development Table 93. Daiichi Sankyo Co Ltd Company Information Table 94. Daiichi Sankyo Co Ltd Business Overview Table 95. Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolio Table 97. Daiichi Sankyo Co Ltd Recent Development Table 98. BioMAS Ltd Company Information Table 99. BioMAS Ltd Business Overview Table 100. BioMAS Ltd Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. BioMAS Ltd Integrin Alpha 4 Product Portfolio Table 102. BioMAS Ltd Recent Development Table 103. Biogen Inc Company Information Table 104. Biogen Inc Business Overview Table 105. Biogen Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Biogen Inc Integrin Alpha 4 Product Portfolio Table 107. Biogen Inc Recent Development Table 108. Antisense Therapeutics Ltd Company Information Table 109. Antisense Therapeutics Ltd Business Overview Table 110. Antisense Therapeutics Ltd Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Antisense Therapeutics Ltd Integrin Alpha 4 Product Portfolio Table 112. Antisense Therapeutics Ltd Recent Development Table 113. Amgen Inc Company Information Table 114. Amgen Inc Business Overview Table 115. Amgen Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Amgen Inc Integrin Alpha 4 Product Portfolio Table 117. Amgen Inc Recent Development Table 118. North America Integrin Alpha 4 Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Integrin Alpha 4 Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 121. North America Integrin Alpha 4 Sales by Type (2027-2032) & (W Units) Table 122. North America Integrin Alpha 4 Sales Price by Type (2021-2026) & (US$/Unit) Table 123. North America Integrin Alpha 4 Sales Price by Type (2027-2032) & (US$/Unit) Table 124. North America Integrin Alpha 4 Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Integrin Alpha 4 Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 127. North America Integrin Alpha 4 Sales by Application (2027-2032) & (W Units) Table 128. North America Integrin Alpha 4 Sales Price by Application (2021-2026) & (US$/Unit) Table 129. North America Integrin Alpha 4 Sales Price by Application (2027-2032) & (US$/Unit) Table 130. North America Integrin Alpha 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Integrin Alpha 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. North America Integrin Alpha 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. North America Integrin Alpha 4 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 134. North America Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 135. North America Integrin Alpha 4 Sales by Country (2027-2032) & (W Units) Table 136. North America Integrin Alpha 4 Sales Price by Country (2021-2026) & (US$/Unit) Table 137. North America Integrin Alpha 4 Sales Price by Country (2027-2032) & (US$/Unit) Table 138. United States Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 139. Canada Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 140. Mexico Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 141. Europe Integrin Alpha 4 Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Integrin Alpha 4 Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 144. Europe Integrin Alpha 4 Sales by Type (2027-2032) & (W Units) Table 145. Europe Integrin Alpha 4 Sales Price by Type (2021-2026) & (US$/Unit) Table 146. Europe Integrin Alpha 4 Sales Price by Type (2027-2032) & (US$/Unit) Table 147. Europe Integrin Alpha 4 Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Integrin Alpha 4 Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 150. Europe Integrin Alpha 4 Sales by Application (2027-2032) & (W Units) Table 151. Europe Integrin Alpha 4 Sales Price by Application (2021-2026) & (US$/Unit) Table 152. Europe Integrin Alpha 4 Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Europe Integrin Alpha 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Integrin Alpha 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Europe Integrin Alpha 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Europe Integrin Alpha 4 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 157. Europe Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 158. Europe Integrin Alpha 4 Sales by Country (2027-2032) & (W Units) Table 159. Europe Integrin Alpha 4 Sales Price by Country (2021-2026) & (US$/Unit) Table 160. Europe Integrin Alpha 4 Sales Price by Country (2027-2032) & (US$/Unit) Table 161. Germany Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 162. France Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 163. U.K. Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 164. Italy Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 165. Russia Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 166. Spain Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 168. Switzerland Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 169. Sweden Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 170. Poland Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 171. China Integrin Alpha 4 Revenue by Type (2021-2026) & (US$ Million) Table 172. China Integrin Alpha 4 Revenue by Type (2027-2032) & (US$ Million) Table 173. China Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 174. China Integrin Alpha 4 Sales by Type (2027-2032) & (W Units) Table 175. China Integrin Alpha 4 Sales Price by Type (2021-2026) & (US$/Unit) Table 176. China Integrin Alpha 4 Sales Price by Type (2027-2032) & (US$/Unit) Table 177. China Integrin Alpha 4 Revenue by Application (2021-2026) & (US$ Million) Table 178. China Integrin Alpha 4 Revenue by Application (2027-2032) & (US$ Million) Table 179. China Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 180. China Integrin Alpha 4 Sales by Application (2027-2032) & (W Units) Table 181. China Integrin Alpha 4 Sales Price by Application (2021-2026) & (US$/Unit) Table 182. China Integrin Alpha 4 Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Integrin Alpha 4 Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Integrin Alpha 4 Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 186. Asia Integrin Alpha 4 Sales by Type (2027-2032) & (W Units) Table 187. Asia Integrin Alpha 4 Sales Price by Type (2021-2026) & (US$/Unit) Table 188. Asia Integrin Alpha 4 Sales Price by Type (2027-2032) & (US$/Unit) Table 189. Asia Integrin Alpha 4 Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Integrin Alpha 4 Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 192. Asia Integrin Alpha 4 Sales by Application (2027-2032) & (W Units) Table 193. Asia Integrin Alpha 4 Sales Price by Application (2021-2026) & (US$/Unit) Table 194. Asia Integrin Alpha 4 Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Asia Integrin Alpha 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Integrin Alpha 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Integrin Alpha 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Integrin Alpha 4 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 199. Asia Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 200. Asia Integrin Alpha 4 Sales by Country (2027-2032) & (W Units) Table 201. Asia Integrin Alpha 4 Sales Price by Country (2021-2026) & (US$/Unit) Table 202. Asia Integrin Alpha 4 Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Japan Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 204. South Korea Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 205. India Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 206. Australia Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 207. Taiwan Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Integrin Alpha 4 Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Integrin Alpha 4 Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 212. SAMEA Integrin Alpha 4 Sales by Type (2027-2032) & (W Units) Table 213. SAMEA Integrin Alpha 4 Sales Price by Type (2021-2026) & (US$/Unit) Table 214. SAMEA Integrin Alpha 4 Sales Price by Type (2027-2032) & (US$/Unit) Table 215. SAMEA Integrin Alpha 4 Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Integrin Alpha 4 Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 218. SAMEA Integrin Alpha 4 Sales by Application (2027-2032) & (W Units) Table 219. SAMEA Integrin Alpha 4 Sales Price by Application (2021-2026) & (US$/Unit) Table 220. SAMEA Integrin Alpha 4 Sales Price by Application (2027-2032) & (US$/Unit) Table 221. SAMEA Integrin Alpha 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Integrin Alpha 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Integrin Alpha 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Integrin Alpha 4 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 225. SAMEA Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 226. SAMEA Integrin Alpha 4 Sales by Country (2027-2032) & (W Units) Table 227. SAMEA Integrin Alpha 4 Sales Price by Country (2021-2026) & (US$/Unit) Table 228. SAMEA Integrin Alpha 4 Sales Price by Country (2027-2032) & (US$/Unit) Table 229. Brazil Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 230. Argentina Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 231. Chile Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 232. Colombia Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 233. Peru Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 235. Israel Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 236. UAE Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 237. Turkey Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 238. Iran Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 239. Egypt Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Integrin Alpha 4 Distributors List Table 243. Integrin Alpha 4 Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Integrin Alpha 4 Image Figure 2. Global Integrin Alpha 4 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Integrin Alpha 4 Market Size Share 2021 VS 2025 VS 2032 Figure 4. ATL-1102 Image Figure 5. Carotegrast Image Figure 6. ET-3764 Image Figure 7. TE-5232 Image Figure 8. Others Image Figure 9. Global Integrin Alpha 4 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Integrin Alpha 4 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Acute Ischemic Stroke Image Figure 12. Melanoma Image Figure 13. Celiac Disease Image Figure 14. Multiple Sclerosis Image Figure 15. Epilepsy Image Figure 16. Other Image Figure 17. Global Integrin Alpha 4 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Integrin Alpha 4 Revenue (2021-2032) & (US$ Million) Figure 19. Global Integrin Alpha 4 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Integrin Alpha 4 Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Integrin Alpha 4 Revenue Market Share by Region (2021-2032) Figure 22. Global Integrin Alpha 4 Sales (2021-2032) & (W Units) Figure 23. Global Integrin Alpha 4 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 24. Global Integrin Alpha 4 Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Integrin Alpha 4 Sales YoY (2021-2032) & (W Units) Figure 26. Europe Integrin Alpha 4 Sales YoY (2021-2032) & (W Units) Figure 27. China Integrin Alpha 4 Sales YoY (2021-2032) & (W Units) Figure 28. Asia (Excluding China) Integrin Alpha 4 Sales YoY (2021-2032) & (W Units) Figure 29. South America, Middle East and Africa Integrin Alpha 4 Sales YoY (2021-2032) & (W Units) Figure 30. Global Integrin Alpha 4 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Integrin Alpha 4 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Integrin Alpha 4 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Integrin Alpha 4 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Integrin Alpha 4 Revenue Market Share by Type (2021-2032) Figure 36. Global Integrin Alpha 4 Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Integrin Alpha 4 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Integrin Alpha 4 Sales Market Share by Type (2021-2032) Figure 39. Global Integrin Alpha 4 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Integrin Alpha 4 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Integrin Alpha 4 Revenue Market Share by Application (2021-2032) Figure 42. Global Integrin Alpha 4 Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 43. Global Integrin Alpha 4 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Integrin Alpha 4 Sales Market Share by Application (2021-2032) Figure 45. North America Integrin Alpha 4 Revenue Share by Type (2021-2032) Figure 46. North America Integrin Alpha 4 Sales Share by Type (2021-2032) Figure 47. North America Integrin Alpha 4 Revenue Share by Application (2021-2032) Figure 48. North America Integrin Alpha 4 Sales Share by Application (2021-2032) Figure 49. North America Integrin Alpha 4 Revenue Share by Country (2021-2032) Figure 50. North America Integrin Alpha 4 Sales Share by Country (2021-2032) Figure 51. Europe Integrin Alpha 4 Revenue Share by Type (2021-2032) Figure 52. Europe Integrin Alpha 4 Sales Share by Type (2021-2032) Figure 53. Europe Integrin Alpha 4 Revenue Share by Application (2021-2032) Figure 54. Europe Integrin Alpha 4 Sales Share by Application (2021-2032) Figure 55. Europe Integrin Alpha 4 Revenue Share by Country (2021-2032) Figure 56. Europe Integrin Alpha 4 Sales Share by Country (2021-2032) Figure 57. China Integrin Alpha 4 Revenue Share by Type (2021-2032) Figure 58. China Integrin Alpha 4 Sales Share by Type (2021-2032) Figure 59. China Integrin Alpha 4 Revenue Share by Application (2021-2032) Figure 60. China Integrin Alpha 4 Sales Share by Application (2021-2032) Figure 61. Asia Integrin Alpha 4 Revenue Share by Type (2021-2032) Figure 62. Asia Integrin Alpha 4 Sales Share by Type (2021-2032) Figure 63. Asia Integrin Alpha 4 Revenue Share by Application (2021-2032) Figure 64. Asia Integrin Alpha 4 Sales Share by Application (2021-2032) Figure 65. Asia Integrin Alpha 4 Revenue Share by Country (2021-2032) Figure 66. Asia Integrin Alpha 4 Sales Share by Country (2021-2032) Figure 67. SAMEA Integrin Alpha 4 Revenue Share by Type (2021-2032) Figure 68. SAMEA Integrin Alpha 4 Sales Share by Type (2021-2032) Figure 69. SAMEA Integrin Alpha 4 Revenue Share by Application (2021-2032) Figure 70. SAMEA Integrin Alpha 4 Sales Share by Application (2021-2032) Figure 71. SAMEA Integrin Alpha 4 Revenue Share by Country (2021-2032) Figure 72. SAMEA Integrin Alpha 4 Sales Share by Country (2021-2032) Figure 73. Integrin Alpha 4 Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Integrin Alpha 4 Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • ATL-1102
  • Carotegrast
  • ET-3764
  • TE-5232
  • Others
Applications
  • Acute Ischemic Stroke
  • Melanoma
  • Celiac Disease
  • Multiple Sclerosis
  • Epilepsy
  • Other
Companies covered
  • Takeda Pharmaceutical Co Ltd
  • Viriom Inc
  • Protagonist Therapeutics Inc
  • Morphic Therapeutic Inc
  • Immunwork Inc
  • EA Pharma Co Ltd
  • Daiichi Sankyo Co Ltd
  • BioMAS Ltd
  • Biogen Inc
  • Antisense Therapeutics Ltd
  • Amgen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Integrin Alpha 4 Market by Type
  3. 1.2.1 Global Integrin Alpha 4 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ATL-1102
  5. 1.2.3 Carotegrast
  6. 1.2.4 ET-3764
  7. 1.2.5 TE-5232
  8. 1.2.6 Others
  9. 1.3 Integrin Alpha 4 Market by Application
  10. 1.3.1 Global Integrin Alpha 4 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Acute Ischemic Stroke
  12. 1.3.3 Melanoma
  13. 1.3.4 Celiac Disease
  14. 1.3.5 Multiple Sclerosis
  15. 1.3.6 Epilepsy
  16. 1.3.7 Other
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Integrin Alpha 4 Market Dynamics
  1. 2.1 Integrin Alpha 4 Industry Trends
  2. 2.2 Integrin Alpha 4 Industry Drivers
  3. 2.3 Integrin Alpha 4 Industry Opportunities and Challenges
  4. 2.4 Integrin Alpha 4 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Integrin Alpha 4 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Integrin Alpha 4 Revenue by Region
  3. 3.2.1 Global Integrin Alpha 4 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Integrin Alpha 4 Revenue by Region (2021-2026)
  5. 3.2.3 Global Integrin Alpha 4 Revenue by Region (2027-2032)
  6. 3.2.4 Global Integrin Alpha 4 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Integrin Alpha 4 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Integrin Alpha 4 Sales by Region
  9. 3.4.1 Global Integrin Alpha 4 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Integrin Alpha 4 Sales by Region (2021-2026)
  11. 3.4.3 Global Integrin Alpha 4 Sales by Region (2027-2032)
  12. 3.4.4 Global Integrin Alpha 4 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Integrin Alpha 4 Revenue by Manufacturers
  2. 4.1.1 Global Integrin Alpha 4 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Integrin Alpha 4 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Integrin Alpha 4 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Integrin Alpha 4 Sales by Manufacturers
  6. 4.2.1 Global Integrin Alpha 4 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Integrin Alpha 4 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Integrin Alpha 4 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Integrin Alpha 4 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Integrin Alpha 4 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Integrin Alpha 4 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Integrin Alpha 4 Manufacturers, Product Type & Application
  13. 4.7 Global Integrin Alpha 4 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Integrin Alpha 4 Market CR5 and HHI
  16. 4.8.2 2025 Integrin Alpha 4 Tier 1, Tier 2, and Tier 3
5 Integrin Alpha 4 Market by Type
  1. 5.1 Global Integrin Alpha 4 Revenue by Type
  2. 5.1.1 Global Integrin Alpha 4 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Integrin Alpha 4 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Integrin Alpha 4 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Integrin Alpha 4 Sales by Type
  6. 5.2.1 Global Integrin Alpha 4 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Integrin Alpha 4 Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Integrin Alpha 4 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Integrin Alpha 4 Price by Type
6 Integrin Alpha 4 Market by Application
  1. 6.1 Global Integrin Alpha 4 Revenue by Application
  2. 6.1.1 Global Integrin Alpha 4 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Integrin Alpha 4 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Integrin Alpha 4 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Integrin Alpha 4 Sales by Application
  6. 6.2.1 Global Integrin Alpha 4 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Integrin Alpha 4 Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Integrin Alpha 4 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Integrin Alpha 4 Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceutical Co Ltd
  2. 7.1.1 Takeda Pharmaceutical Co Ltd Company Information
  3. 7.1.2 Takeda Pharmaceutical Co Ltd Business Overview
  4. 7.1.3 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolio
  6. 7.1.5 Takeda Pharmaceutical Co Ltd Recent Developments
  7. 7.2 Viriom Inc
  8. 7.2.1 Viriom Inc Company Information
  9. 7.2.2 Viriom Inc Business Overview
  10. 7.2.3 Viriom Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Viriom Inc Integrin Alpha 4 Product Portfolio
  12. 7.2.5 Viriom Inc Recent Developments
  13. 7.3 Protagonist Therapeutics Inc
  14. 7.3.1 Protagonist Therapeutics Inc Company Information
  15. 7.3.2 Protagonist Therapeutics Inc Business Overview
  16. 7.3.3 Protagonist Therapeutics Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Protagonist Therapeutics Inc Integrin Alpha 4 Product Portfolio
  18. 7.3.5 Protagonist Therapeutics Inc Recent Developments
  19. 7.4 Morphic Therapeutic Inc
  20. 7.4.1 Morphic Therapeutic Inc Company Information
  21. 7.4.2 Morphic Therapeutic Inc Business Overview
  22. 7.4.3 Morphic Therapeutic Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Morphic Therapeutic Inc Integrin Alpha 4 Product Portfolio
  24. 7.4.5 Morphic Therapeutic Inc Recent Developments
  25. 7.5 Immunwork Inc
  26. 7.5.1 Immunwork Inc Company Information
  27. 7.5.2 Immunwork Inc Business Overview
  28. 7.5.3 Immunwork Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Immunwork Inc Integrin Alpha 4 Product Portfolio
  30. 7.5.5 Immunwork Inc Recent Developments
  31. 7.6 EA Pharma Co Ltd
  32. 7.6.1 EA Pharma Co Ltd Company Information
  33. 7.6.2 EA Pharma Co Ltd Business Overview
  34. 7.6.3 EA Pharma Co Ltd Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 EA Pharma Co Ltd Integrin Alpha 4 Product Portfolio
  36. 7.6.5 EA Pharma Co Ltd Recent Developments
  37. 7.7 Daiichi Sankyo Co Ltd
  38. 7.7.1 Daiichi Sankyo Co Ltd Company Information
  39. 7.7.2 Daiichi Sankyo Co Ltd Business Overview
  40. 7.7.3 Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolio
  42. 7.7.5 Daiichi Sankyo Co Ltd Recent Developments
  43. 7.8 BioMAS Ltd
  44. 7.8.1 BioMAS Ltd Company Information
  45. 7.8.2 BioMAS Ltd Business Overview
  46. 7.8.3 BioMAS Ltd Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 BioMAS Ltd Integrin Alpha 4 Product Portfolio
  48. 7.8.5 BioMAS Ltd Recent Developments
  49. 7.9 Biogen Inc
  50. 7.9.1 Biogen Inc Company Information
  51. 7.9.2 Biogen Inc Business Overview
  52. 7.9.3 Biogen Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Biogen Inc Integrin Alpha 4 Product Portfolio
  54. 7.9.5 Biogen Inc Recent Developments
  55. 7.10 Antisense Therapeutics Ltd
  56. 7.10.1 Antisense Therapeutics Ltd Company Information
  57. 7.10.2 Antisense Therapeutics Ltd Business Overview
  58. 7.10.3 Antisense Therapeutics Ltd Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Antisense Therapeutics Ltd Integrin Alpha 4 Product Portfolio
  60. 7.10.5 Antisense Therapeutics Ltd Recent Developments
  61. 7.11 Amgen Inc
  62. 7.11.1 Amgen Inc Company Information
  63. 7.11.2 Amgen Inc Business Overview
  64. 7.11.3 Amgen Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Amgen Inc Integrin Alpha 4 Product Portfolio
  66. 7.11.5 Amgen Inc Recent Developments
8 North America
  1. 8.1 North America Integrin Alpha 4 Market Size by Type
  2. 8.1.1 North America Integrin Alpha 4 Revenue by Type (2021-2032)
  3. 8.1.2 North America Integrin Alpha 4 Sales by Type (2021-2032)
  4. 8.1.3 North America Integrin Alpha 4 Price by Type (2021-2032)
  5. 8.2 North America Integrin Alpha 4 Market Size by Application
  6. 8.2.1 North America Integrin Alpha 4 Revenue by Application (2021-2032)
  7. 8.2.2 North America Integrin Alpha 4 Sales by Application (2021-2032)
  8. 8.2.3 North America Integrin Alpha 4 Price by Application (2021-2032)
  9. 8.3 North America Integrin Alpha 4 Market Size by Country
  10. 8.3.1 North America Integrin Alpha 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Integrin Alpha 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Integrin Alpha 4 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Integrin Alpha 4 Market Size by Type
  2. 9.1.1 Europe Integrin Alpha 4 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Integrin Alpha 4 Sales by Type (2021-2032)
  4. 9.1.3 Europe Integrin Alpha 4 Price by Type (2021-2032)
  5. 9.2 Europe Integrin Alpha 4 Market Size by Application
  6. 9.2.1 Europe Integrin Alpha 4 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Integrin Alpha 4 Sales by Application (2021-2032)
  8. 9.2.3 Europe Integrin Alpha 4 Price by Application (2021-2032)
  9. 9.3 Europe Integrin Alpha 4 Market Size by Country
  10. 9.3.1 Europe Integrin Alpha 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Integrin Alpha 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Integrin Alpha 4 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Integrin Alpha 4 Market Size by Type
  2. 10.1.1 China Integrin Alpha 4 Revenue by Type (2021-2032)
  3. 10.1.2 China Integrin Alpha 4 Sales by Type (2021-2032)
  4. 10.1.3 China Integrin Alpha 4 Price by Type (2021-2032)
  5. 10.2 China Integrin Alpha 4 Market Size by Application
  6. 10.2.1 China Integrin Alpha 4 Revenue by Application (2021-2032)
  7. 10.2.2 China Integrin Alpha 4 Sales by Application (2021-2032)
  8. 10.2.3 China Integrin Alpha 4 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Integrin Alpha 4 Market Size by Type
  2. 11.1.1 Asia Integrin Alpha 4 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Integrin Alpha 4 Sales by Type (2021-2032)
  4. 11.1.3 Asia Integrin Alpha 4 Price by Type (2021-2032)
  5. 11.2 Asia Integrin Alpha 4 Market Size by Application
  6. 11.2.1 Asia Integrin Alpha 4 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Integrin Alpha 4 Sales by Application (2021-2032)
  8. 11.2.3 Asia Integrin Alpha 4 Price by Application (2021-2032)
  9. 11.3 Asia Integrin Alpha 4 Market Size by Country
  10. 11.3.1 Asia Integrin Alpha 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Integrin Alpha 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Integrin Alpha 4 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Integrin Alpha 4 Market Size by Type
  2. 12.1.1 SAMEA Integrin Alpha 4 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Integrin Alpha 4 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Integrin Alpha 4 Price by Type (2021-2032)
  5. 12.2 SAMEA Integrin Alpha 4 Market Size by Application
  6. 12.2.1 SAMEA Integrin Alpha 4 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Integrin Alpha 4 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Integrin Alpha 4 Price by Application (2021-2032)
  9. 12.3 SAMEA Integrin Alpha 4 Market Size by Country
  10. 12.3.1 SAMEA Integrin Alpha 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Integrin Alpha 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Integrin Alpha 4 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Integrin Alpha 4 Value Chain Analysis
  2. 13.1.1 Integrin Alpha 4 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Integrin Alpha 4 Production Mode & Process
  6. 13.2 Integrin Alpha 4 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Integrin Alpha 4 Distributors
  9. 13.2.3 Integrin Alpha 4 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst